Literature DB >> 19941324

Evidence of effectiveness of herbal medicinal products in the treatment of arthritis. Part 2: Rheumatoid arthritis.

Melainie Cameron1, Joel J Gagnier, Christine V Little, Tessa J Parsons, Anette Blümle, Sigrun Chrubasik.   

Abstract

Herbal medicinal products (HMPs) that interact with the mediators of inflammation are used in the treatment of rheumatoid arthritis (RA). The aim of this study was to update a previous systematic review published in 2000. We searched electronic databases (MEDLINE, EMBASE, CISCOM, AMED, CINAHL, Cochrane registers) to June 2007, unrestricted by date or language, and included randomized controlled trials that compared HMPs with inert (placebo) or active controls in patients with rheumatoid arthritis. Five reviewers contributed to data extraction. Disagreements were discussed and resolved by consensus with reference to Cochrane guidelines and advice from the Cochrane Collaboration. Twenty studies (10 identified for this review update, and 10 of the 11 studies of the original review) investigating 14 HMPs were included. Meta-analysis was restricted to data from previous seven studies with oils from borage, blackcurrant and evening primrose containing gamma linolenic acid (GLA). GLA doses equal or higher than 1400 mg/day showed benefit in the alleviation of rheumatic complaints whereas lower doses ( approximately 500 mg) were ineffective. Three studies compared products from Tripterygium wilfordii (thunder god vine) to placebos and returned favorable results but data could not be pooled because the interventions and measures differed. Serious adverse effects occurred in one study. In a follow-up study all side effects were mild to moderate and resolved after the intervention ceased, but time to resolution was variable. Two studies comparing Phytodolor NR to placebo were of limited use because some measures were poorly defined. The remaining studies, each considering differing HMPs, were assessed individually. For most HMPs used in the treatment of RA, the evidence of effectiveness was insufficient to either recommend or discourage their use. Interventions with HMPs containing GLA or Tripterygium wilfordii extract appear to produce therapeutic effects but further investigations are warranted to prove their effectiveness and safety. Copyright (c) 2009 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19941324     DOI: 10.1002/ptr.3006

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  14 in total

1.  Microarray-based gene expression profiling reveals the mediators and pathways involved in the anti-arthritic activity of Celastrus-derived Celastrol.

Authors:  Hua Yu; Shivaprasad H Venkatesha; Kamal D Moudgil
Journal:  Int Immunopharmacol       Date:  2012-06-02       Impact factor: 4.932

2.  Incorporation of n-3 PUFA and γ-linolenic acid in blood lipids and red blood cell lipids together with their influence on disease activity in patients with chronic inflammatory arthritis--a randomized controlled human intervention trial.

Authors:  Christine Dawczynski; Ursula Hackermeier; Martin Viehweger; Rainer Stange; Monika Springer; Gerhard Jahreis
Journal:  Lipids Health Dis       Date:  2011-08-04       Impact factor: 3.876

Review 3.  Tripterygium wilfordii Hook F versus conventional synthetic disease-modifying anti-rheumatic drugs as monotherapy for rheumatoid arthritis: a systematic review and network meta-analysis.

Authors:  Hai-Long Wang; Quan Jiang; Xing-Hua Feng; Hua-Dong Zhang; Lin Ge; Cheng-Gui Luo; Xun Gong; Bo Li
Journal:  BMC Complement Altern Med       Date:  2016-07-13       Impact factor: 3.659

4.  Genetic Diversity and Genetic Relationships of Purple Willow (Salix purpurea L.) from Natural Locations.

Authors:  Paweł Sulima; Kathleen Prinz; Jerzy A Przyborowski
Journal:  Int J Mol Sci       Date:  2017-12-30       Impact factor: 5.923

5.  STUDIES ON THE INTERACTION BETWEEN TRIPTOLIDE AND BOVINE SERUM ALBUMIN (BSA) BY SPECTROSCOPIC AND MOLECULAR MODELING METHODS.

Authors:  Haidong Wang; Hailang Shi; Jie Pang; Xingfa Song; Caiyun Xu; Zengxian Sun
Journal:  Afr J Tradit Complement Altern Med       Date:  2016-09-29

6.  Clinical Benefits of n-3 PUFA and ɤ-Linolenic Acid in Patients with Rheumatoid Arthritis.

Authors:  Mirjana Veselinovic; Dragan Vasiljevic; Vesna Vucic; Aleksandra Arsic; Snjezana Petrovic; Aleksandra Tomic-Lucic; Maja Savic; Sandra Zivanovic; Vladislava Stojic; Vladimir Jakovljevic
Journal:  Nutrients       Date:  2017-03-25       Impact factor: 5.717

7.  Celastrol inhibits lipopolysaccharide-stimulated rheumatoid fibroblast-like synoviocyte invasion through suppression of TLR4/NF-κB-mediated matrix metalloproteinase-9 expression.

Authors:  Guoqing Li; Dan Liu; Yu Zhang; Yayun Qian; Hua Zhang; Shiyu Guo; Masataka Sunagawa; Tadashi Hisamitsu; Yanqing Liu
Journal:  PLoS One       Date:  2013-07-04       Impact factor: 3.240

8.  Anti-invasive effects of Celastrus Orbiculatus extract on interleukin-1 beta and tumour necrosis factor-alpha combination-stimulated fibroblast-like synoviocytes.

Authors:  Guoqing Li; Dan Liu; Shiyu Guo; Masataka Sunagawa; Tadashi Hisamitsu; Yanqing Liu
Journal:  BMC Complement Altern Med       Date:  2014-02-19       Impact factor: 3.659

9.  Predicting and verifying outcome of Tripterygium wilfordii Hook F. based therapy in rheumatoid arthritis: from open to double-blinded randomized trial.

Authors:  Miao Jiang; Qinglin Zha; Chi Zhang; Cheng Lu; Xiaoping Yan; Wanhua Zhu; Wei Liu; Shenghao Tu; Liping Hou; Chengwu Wang; Wandong Zhang; Qinghua Liang; Bing Fan; Jiangping Yu; Weidong Zhang; Xinru Liu; Jing Yang; Xiaojuan He; Li Li; Xuyan Niu; Yan Liu; Hongtao Guo; Bing He; Ge Zhang; Zhaoxiang Bian; Aiping Lu
Journal:  Sci Rep       Date:  2015-04-15       Impact factor: 4.379

10.  Efficacy of JOINS on Cartilage Protection in Knee Osteoarthritis: Prospective Randomized Controlled Trial.

Authors:  Joong Il Kim; Ja Young Choi; Kwang Gi Kim; Myung Chul Lee
Journal:  Knee Surg Relat Res       Date:  2017-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.